3-generation family medical histories of mental, neurologic, cardiometabolic, birth defect, asthma, allergy, and autoimmune conditions associated with autism.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
04 Nov 2023
04 Nov 2023
Historique:
pubmed:
14
11
2023
medline:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
Family histories of different mental and non-mental conditions have often been associated with autism spectrum disorder (ASD) but the restricted scope of conditions and family members that have been investigated limits etiologic understanding. We aimed to perform a comprehensive assessment of ASD associations with 3-generation family histories of 90 mental, neurologic, cardiometabolic, birth defect, asthma, allergy, and autoimmune conditions. The assessment comprised separate estimates of association with ASD overall; separate estimates by sex and intellectual disability (ID) status; as well as separate estimates of the co-occurrence of each of the 90 disorders in autistic persons. Additionally, we aimed to provide interactive catalogues of results to facilitate results visualization and further hypothesis-generation. We conducted a population-based, registry cohort study comprised of all live births in Denmark, 1980-2012, of Denmark-born parents, and with birth registry information (1,697,231 births), and their 3-generation family member types (20 types). All cohort members were followed from birth through April 10, 2017 for an ASD diagnosis. All participants (cohort members and each family member) were followed from birth through April 10, 2017 for each of 90 diagnoses, emigration or death. Adjusted hazard ratios (aHR) were estimated for ASD overall; by sex; or accounting for ID via separate Cox regression models for each diagnosis-family member type combination, adjusting for birth year, sex, birth weight, gestational age, parental ages at birth, and number of family member types of index person. aHRs were also calculated for sex-specific co-occurrence of each disorder, for ASD overall and considering ID. A catalogue of all results is displayed via interactive heat maps here: https://ncrr-au.shinyapps.io/asd-riskatlas/ and interactive graphic summaries of results are here: https://public.tableau.com/views/ASDPlots_16918786403110/e-Figure5. Increased aHRs for ASD (26,840 cases; 1.6% of births) were observed for almost all individual mental disorder-family member type combinations yet for fewer non-mental disorder-family member type combinations. aHRs declined with diminishing degree of relatedness between the index person and family member for some disorders, especially mental disorders. Variation in aHR magnitude by family member sex (e.g., higher maternal than paternal aHRs) or side of the family (e.g., higher maternal versus paternal half sibling aHRs) was more evident among non-mental than mental disorders. Co-occurring ID in the family member or the index person impacted aHR variation. Our approach revealed considerable breadth and variation in magnitude of familial health history associations with ASD by type of condition, sex of the affected family member, side of the family, sex of the index person, and ID status which is indicative of diverse genetic, familial, and non-genetic ASD etiologic pathways. More careful attention to identifying sources of autism likelihood encompassed in family medical history, in addition to genetics, may accelerate understanding of factors underlying neurodiversity.
Sections du résumé
Background
UNASSIGNED
Family histories of different mental and non-mental conditions have often been associated with autism spectrum disorder (ASD) but the restricted scope of conditions and family members that have been investigated limits etiologic understanding. We aimed to perform a comprehensive assessment of ASD associations with 3-generation family histories of 90 mental, neurologic, cardiometabolic, birth defect, asthma, allergy, and autoimmune conditions. The assessment comprised separate estimates of association with ASD overall; separate estimates by sex and intellectual disability (ID) status; as well as separate estimates of the co-occurrence of each of the 90 disorders in autistic persons. Additionally, we aimed to provide interactive catalogues of results to facilitate results visualization and further hypothesis-generation.
Methods
UNASSIGNED
We conducted a population-based, registry cohort study comprised of all live births in Denmark, 1980-2012, of Denmark-born parents, and with birth registry information (1,697,231 births), and their 3-generation family member types (20 types). All cohort members were followed from birth through April 10, 2017 for an ASD diagnosis. All participants (cohort members and each family member) were followed from birth through April 10, 2017 for each of 90 diagnoses, emigration or death. Adjusted hazard ratios (aHR) were estimated for ASD overall; by sex; or accounting for ID via separate Cox regression models for each diagnosis-family member type combination, adjusting for birth year, sex, birth weight, gestational age, parental ages at birth, and number of family member types of index person. aHRs were also calculated for sex-specific co-occurrence of each disorder, for ASD overall and considering ID. A catalogue of all results is displayed via interactive heat maps here: https://ncrr-au.shinyapps.io/asd-riskatlas/ and interactive graphic summaries of results are here: https://public.tableau.com/views/ASDPlots_16918786403110/e-Figure5.
Results
UNASSIGNED
Increased aHRs for ASD (26,840 cases; 1.6% of births) were observed for almost all individual mental disorder-family member type combinations yet for fewer non-mental disorder-family member type combinations. aHRs declined with diminishing degree of relatedness between the index person and family member for some disorders, especially mental disorders. Variation in aHR magnitude by family member sex (e.g., higher maternal than paternal aHRs) or side of the family (e.g., higher maternal versus paternal half sibling aHRs) was more evident among non-mental than mental disorders. Co-occurring ID in the family member or the index person impacted aHR variation.
Conclusion
UNASSIGNED
Our approach revealed considerable breadth and variation in magnitude of familial health history associations with ASD by type of condition, sex of the affected family member, side of the family, sex of the index person, and ID status which is indicative of diverse genetic, familial, and non-genetic ASD etiologic pathways. More careful attention to identifying sources of autism likelihood encompassed in family medical history, in addition to genetics, may accelerate understanding of factors underlying neurodiversity.
Identifiants
pubmed: 37961212
doi: 10.1101/2023.11.03.23298042
pmc: PMC10635276
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIEHS NIH HHS
ID : R01 ES026993
Pays : United States
Déclaration de conflit d'intérêts
Competing Interest Statement The authors have no competing interests to declare.
Références
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
J Autism Dev Disord. 2016 Jan;46(1):95-102
pubmed: 26254893
Arch Gen Psychiatry. 2011 Nov;68(11):1095-102
pubmed: 21727249
Pharmacol Res. 2017 May;119:384-390
pubmed: 28238829
Nat Immunol. 2001 Sep;2(9):777-80
pubmed: 11526384
Int J Epidemiol. 2016 Aug;45(4):1236-1246
pubmed: 27170762
Front Neuroendocrinol. 2014 Aug;35(3):347-69
pubmed: 24793874
JAMA. 2015 Apr 14;313(14):1425-34
pubmed: 25871668
J Am Acad Child Adolesc Psychiatry. 2019 May;58(5):496-505
pubmed: 30975444
Obes Facts. 2015;8(5):319-28
pubmed: 26465142
Epilepsia. 2016 Dec;57(12):2011-2018
pubmed: 27861783
Am J Hum Genet. 2022 Dec 1;109(12):2152-2162
pubmed: 36347255
Gend Med. 2007;4 Suppl B:S133-46
pubmed: 18156099
Pediatrics. 2014 May;133(5):e1128-38
pubmed: 24709932
JAMA Netw Open. 2019 Mar 1;2(3):e190154
pubmed: 30821823
Thorax. 2012 Jul;67(7):625-31
pubmed: 22334535
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Arch Pediatr Adolesc Med. 2005 Feb;159(2):151-7
pubmed: 15699309
Allergy. 2008 May;63(5):610-5
pubmed: 18394135
JAMA. 2009 Feb 11;301(6):636-50
pubmed: 19211471
JAMA Pediatr. 2013 Oct;167(10):947-53
pubmed: 23959427
Neurosci Biobehav Rev. 2015 Aug;55:322-32
pubmed: 25981892
Dev Med Child Neurol. 2009 Oct;51(10):779-86
pubmed: 19416313
Int J Obes (Lond). 2014 Jun;38(6):878-82
pubmed: 24362506
Psychol Med. 2018 May;48(7):1201-1208
pubmed: 28942743
Diabetologia. 2012 Feb 8;:
pubmed: 22314812
Teratology. 2001 Nov;64(5):237-51
pubmed: 11745830
J Autoimmun. 2012 May;38(2-3):J275-81
pubmed: 22218218
J Child Psychol Psychiatry. 1989 May;30(3):405-16
pubmed: 2745591
Dan Med Bull. 1998 Jun;45(3):320-3
pubmed: 9675544
Arch Gen Psychiatry. 2012 Nov;69(11):1099-1103
pubmed: 22752149
Hum Genet. 2015 Feb;134(2):259-67
pubmed: 25543539
PLoS One. 2012;7(4):e33224
pubmed: 22511918
Hum Reprod Update. 2014 Jul-Aug;20(4):582-93
pubmed: 24619876
J Autoimmun. 2012 May;38(2-3):J266-74
pubmed: 22284905
JAMA Psychiatry. 2019 Mar 1;76(3):259-270
pubmed: 30649197
Am J Psychiatry. 2010 Nov;167(11):1357-63
pubmed: 20686188
Am J Hum Genet. 2020 May 7;106(5):587-595
pubmed: 32359473
Pediatrics. 2009 Aug;124(2):687-94
pubmed: 19581261
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
J Am Acad Child Adolesc Psychiatry. 2019 Sep;58(9):866-875
pubmed: 30851399
Dev Med Child Neurol. 2014 Jan;56(1):59-65
pubmed: 24117446
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Autism. 2015 Oct;19(7):814-23
pubmed: 25911091
Psychiatry Res. 2013 May 30;207(3):203-11
pubmed: 23391634
Eur Heart J. 2016 Feb 7;37(6):561-7
pubmed: 26392438
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Pediatrics. 2008 May;121(5):e1357-62
pubmed: 18450879
Psychol Med. 1995 Jan;25(1):63-77
pubmed: 7792363
Dev Med Child Neurol. 2006 Jun;48(6):500-7
pubmed: 16700944
Birth Defects Res A Clin Mol Teratol. 2004 Jun;70(6):371-81
pubmed: 15211705
JAMA. 2014 May 7;311(17):1770-7
pubmed: 24794370